Ketamine-Assisted Psychotherapy for Anxiety with Thomas Kim, MD

Ketamine-Assisted Psychotherapy for Anxiety with Thomas Kim, MD

Author: Lynn Marie Morski, MD, JD February 19, 2025 Duration: 41:13

In this episode, Thomas Kim, MD joins to discuss ketamine-assisted psychotherapy for anxiety. Dr. Kim is the Chief Medical Officer of Noma Therapy, which is a ketamine-assisted psychotherapy program available via telehealth and in-person with licensed therapists. He has devoted 20 years of his professional life to realizing a value-based approach to healthcare through telehealth.

In this conversation, Dr. Kim shares his journey of working in early telehealth contexts to now working with ketamine. He discusses the research on ketamine treatments for anxiety and explains the significant comorbidity of anxiety, depression, and PTSD, stressing that anxiety is best understood from a more holistic perspective that considers the social determinants of health. Dr. Kim also emphasizes the importance of psychotherapy alongside ketamine dosing sessions, explaining that therapists have a window of opportunity in the days following the ketamine dose to best take advantage of the state of ketamine-induced neuroplasticity the patient is experiencing. In closing, Dr. Kim shares his philosophy of prescribing the least amount of medicine which produces the largest impact for the patient to ensure that side effects are mitigated and financial burdens are reduced. 

 

In this episode you'll hear:

  • Balancing maximal safety and maximal accessibility in medicine
  • The research on ketamine treatments for anxiety
  • How psychotherapy fits with ketamine treatments
  • The neuroscience of why patients can have strong emotional reactions following ketamine sessions
  • Stories of success from Dr. Kim's practice
  • The importance of understanding how adverse childhood experiences and social determinants of health significantly contribute to mental health struggles
  • Collaborative ketamine-assisted psychotherapy with a patient's existing therapist

 

Quotes:

"Over time, continued effort in the field [of telehealth] has led to cost-effective, scalable solutions that can reach more people. I'm really hopeful that we can find solutions in the psychedelic and ketamine landscape to do a similar thing." [5:36]

"A thing that I say routinely to patients is 'there is no cure in the bottom of the pill bottle—ketamine included.' They are all incredibly useful and, when used effectively, can provide you meaningful relief from your psychological distress but make no mistake, there is not a cure—which is why I'm such a huge advocate of therapy and which is why ketamine-assisted psychotherapy also needs to be distinguished from ketamine therapy."  [14:21]

"[We created] an intentionally time-limited plan which places the emphasis on the fact that, one day, you're going to drive your own bus and you're not going to need me. It's a terrible business model—in fact it's a wonderful business model because it gives us an opportunity to take care of more people because we set the intention of 'Ketamine is not forever. You're not broken. You're struggling and we're going to get you to a place where you might not need us.'"  [34:04]

 

Links:

Dr. Kim on LinkedIn

Noma Therapy website

Psychedelic Medicine Association

Porangui

 


Exploring the frontier of mind and medicine, the Psychedelic Medicine Podcast with Dr. Lynn Marie Morski delves into the complex world of psychedelic substances and their potential to heal. Hosted by Lynn Marie Morski, a physician and attorney, this podcast navigates the intricate intersection of cutting-edge science, clinical practice, and evolving policy. Each episode brings a grounded, expert perspective to conversations about psilocybin, MDMA, ketamine, LSD, ayahuasca, ibogaine, and other compounds, moving beyond hype to examine the real-world implications of this therapeutic renaissance. Listeners will hear detailed discussions on the latest peer-reviewed research, practical insights from medical professionals integrating these approaches, and thoughtful analysis of the legal landscape shaping access. The dialogue is rooted in a commitment to safety, ethics, and evidence, offering a clear-eyed look at both the profound promise and the challenges inherent in psychedelic medicine. Whether you're a healthcare provider, a patient, a researcher, or simply intellectually curious, this podcast provides an essential, nuanced resource for understanding how these ancient and modern substances are reshaping perspectives on mental health, consciousness, and treatment. It’s a space for serious inquiry, where complex questions about healing, neuroscience, and society are met with informed, accessible conversation.
Author: Language: English Episodes: 50

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski
Podcast Episodes
Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD [not-audio_url] [/not-audio_url]

Duration: 39:32
In this episode of the Psychedelic Medicine Podcast, Fernando Rivas, MD, joins to unpack the safety and screening considerations for ibogaine therapy. Dr. Rivas is an emergency physician with over 15 years of clinical ex…
Encore Episode: Psychedelics and Breathwork with Kyle Buller [not-audio_url] [/not-audio_url]

Duration: 43:58
This encore episode of the Psychdelic Medicine Podcast features a conversation with Kyle Buller on psychedelics and breathwork. Kyle is co-founder and host of the Psychedelics Today podcast and he has studied breathwork…
Psychedelics and Psychosis with Alexander Lebedev, MD, PhD [not-audio_url] [/not-audio_url]

Duration: 46:09
In this episode of the Psychedelic Medicine Podcast, Alexander Lebedev, MD, PhD joins to discuss psychedelic medicine and psychosis. Dr. Lebedev is a physician-scientist, medical AI engineer, and entrepreneur working at…
Psychedelics and GLP-1s with Arsalan Azam, MD [not-audio_url] [/not-audio_url]

Duration: 36:22
In this episode of the Psychedelic Medicine Podcast, Arsalan Azam, MD joins to unpack the intersection between psychedelics and GLP-1s. Dr. Azam, founder of Daydream MD, completed his residency in Emergency Medicine at t…
Psilocybin vs. Ketamine with Dori Lewis, LPC [not-audio_url] [/not-audio_url]

Duration: 43:11
In this episode of the Psychedelic Medicine Podcast, Dori Lewis, MA, MEd, LPC-S returns to discuss the differences between psilocybin and ketamine. Dori is the Clinical Director of Elemental Psychedelics and Owner/Operat…
Choosing the Right Ketamine Clinic for You with Katie Fassbinder, MD [not-audio_url] [/not-audio_url]

Duration: 50:19
In this episode of the Psychedelic Medicine Podcast, Katie Fassbinder, MD joins to explore how to choose the right ketamine clinic. Dr. Fassbinder is the Faculty Medical Lead for ketamine-assisted psychotherapy training…
The Future of Psychedelic Medicine with Ismail Lourido Ali, JD [not-audio_url] [/not-audio_url]

Duration: 52:24
In the 200th episode of the Psychedelic Medicine Podcast, Ismail Lourido Ali, JD joins to discuss the future of psychedelic medicine. Ismail serves as MAPS Co-Executive Director and has been actively participating in the…
Psychedelics and Neurodiversity with Dr. WaiFung Tsang, DClinPsy [not-audio_url] [/not-audio_url]

Duration: 43:31
In this episode, Dr. WaiFung Tsang, DClinPsy joins to discuss the intersection of psychedelics and neurodiversity. Dr. Tsang is a clinical research psychologist from Hong Kong, musician, and student of Shipibo curanderis…